IMF focuses on cancer, autoimmune diseases, asthma and COPD, Parkinson’s disease and neurodegenerative disorders, acute and chronic infective diseases and orphan (rare) disorders. The list of the diseases includes: Autoimmune (Idiopathic Thrombocytopenia) – ITP, Chronic Glomerulonephritis, Myasthenia Gravis, Hard-to-treat autoimmune and vascular ocular diseases, Diabetes type I and II, Asthma, COPD and Pulmonary Fibrotic diseases, Ulcerative Colitis and Crohn’s diseases, Eczema, Psoriasis, Scleroderma, Autoimmune Hepatitis, Primary Biliary Cirrhosis, Sclerosing Cholangitis, Lupus and systemic vasculitis, Cancer, cancer pain and cachexia, Aplastic anemia, Myelodysplastic disorders and Myelofibrosis. These diseases have been successfully treated based on our more than 30 years of clinical practice and medical research.
The Inventive Medical Foundation is pleased to announce its support for an exciting collaborative research and development project between Professor Ba X. Hoang, M.D., Ph.D. of the Keck School of Medicine of the University of Southern California (USC) and Professor Bo Han and the UCLA research team, led by Professor Varghese John, Ph.D., at the David Geffen School of Medicine at UCLA.
The funded project focuses on developing an innovative therapeutic strategy for Alzheimer’s disease and related dementias by advancing a novel synthetic exosome platform. This pioneering research aims to establish new approaches for treating neurodegenerative disorders that continue to affect millions of patients and families worldwide.
The Inventive Medical Foundation is honored to support this outstanding partnership between leading investigators at USC and UCLA. By bringing together expertise in neurology, drug discovery, and innovative therapeutic development, this collaboration represents a significant step toward creating next-generation treatments for Alzheimer’s disease and dementia.
The Foundation is encouraged by the excellent progress made during the project’s early stages and has high expectations that this collaborative effort will lead to meaningful scientific advances and, ultimately, improved therapeutic options for patients suffering from these devastating neurological disorders.
Inventive Medical Foundation remains committed to supporting innovative biomedical research that advances human health and accelerates the translation of groundbreaking discoveries into clinical applications for patients worldwide.
